SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA

People with type 2 diabetes (T2D) with concomitant chronic kidney disease (CKD) and cardiovascular (CV) disease are at increased risk for recurrent CV events and hypoglycemia. Treatment of these individuals is clinically challenging, where the evidence-base for safety and efficacy of glucose lowerin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Endocr Soc
Hoofdauteurs: Kahn, Steven, Perkovic, Vlado, Johansen, Odd Erik, Rosenstock, Julio, McGuire, Darren, Toto, Robert, Nikolaus, Marx, Alexander, John, Zinman, Bernard, Pfarr, Egon, Schnaidt, Sven, Meinicke, Thomas, George, Jyothis, von Eynatten, Max, Cooper, Mark, Wanner, Christoph
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Endocrine Society 2019
Onderwerpen:
Cardiovascular Endocrinology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553362/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB015
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items